TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Sema4 Stock

Sema4 Stock

sema4.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $368.26MM

Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.

Learn more about Sema4 IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Sema4, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Sema4’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sema4.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Other companies like Sema4 in the Healthcare providers & services sector

Mark Cuban Cost Plus Drug Company

Sector
Healthcare / Healthcare providers & services
 
 

Solv Health

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$399.84MM

SWORD Health

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$1.81B

HeartFlow

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$1.65B

VillageMD

Sector
Healthcare / Healthcare providers & services
 
 

Capsule

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$458.12MM

Dandy

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$10.41MM

Collective Health

Sector
Healthcare / Healthcare providers & services
Last Round Est. Valuation
$281.98MM

SnapNurse

Sector
Healthcare / Healthcare providers & services
 
 

News Highlights

Genomeweb 03/16/2022
Sema4 to Study Precision Oncology Disparities in Nationwide Biobanking, Genomic Profiling Study
The firm will use its suite of assays to characterize samples from 5,000 advanced cancer patients from underserved communities and create a representative biobank.
Genomeweb 03/15/2022
Sema4 Q4 Revenues Decline 10 Percent
Sema4 beat the consensus Wall Street estimate on the top and bottom lines for Q4 and said it expects between $215 million and $225 million in revenues for 2022.

Trending Companies

Frequently Asked Questions

Updated on: Apr 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.